Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Projections of COPD in males in the Netherlands

N. B. Pride
European Respiratory Journal 2006 27: 240-241; DOI: 10.1183/09031936.06.00107605
N. B. Pride
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

To the Editors:

In a recent issue of the European Respiratory Journal, projections for a large increase in chronic obstructive pulmonary disease (COPD) in females in the Netherlands up to 2025 were recorded in the study by Hoogendoorn et al. 1. These are depressing, but expected given recent observed trends and the modest changes in smoking made by Dutch females since 1980 2, 3. However, males in the Netherlands, who had the highest known usage of tobacco products per adult of any country from the 1930s to the 1950s 2, have considerably reduced their cigarette consumption since the 1970s 2, 3. Therefore, it is disconcerting to see that continuing upward trends in COPD, albeit smaller in scale, are also projected for Dutch males. Where the predicted time trend is shown 1, there is little, if any, slowing of the rate of increase over the whole period up to 2025. In contrast, according to the World Health Organization (WHO) compilation of national statistics presented by Peto et al. 4, total deaths from lung cancer have recently begun to fall in males within the European Union. In the Netherlands, total male deaths from lung cancer and rates per 100,000 in both the total adult population, and those aged 75–79 yrs, all declined progressively between 1985 and 2000. As discussed in the accompanying editorial by Mannino 5, and elsewhere 6, slower and less dramatic benefits would be expected in COPD than in lung cancer after quitting smoking. Nevertheless, WHO data on COPD mortality in the Netherlands 4 also indicate that between 1990 and 2000 total male deaths have been stable, whereas death rates per 100,000 for the total adult population, and for males aged 75–79 yrs, have both declined by a similar proportionate amount.

While recognising that the primary purpose of the authors' model is to estimate total future costs due to chronic obstructive pulmonary disease, regardless of how these costs arise, the authors hardly comment on the extent to which their estimates depend on demographic changes, in particular, increased age of the population (which perhaps represents medical “success” but increases costs and worries pension funds) and how much depends on the persistence of smoking-related disease (which is amenable to preventive medicine). The increases presented for prevalence and mortality could potentially be explained entirely by population ageing, but there is no quantification of these two major factors to support or refute this possibility. Such information might help the medical reader to better understand the paradox that, while smoking is the most important aetiological factor for causing physician-diagnosed chronic obstructive pulmonary disease, its prevalence and mortality can be projected to continue to increase even after 45 yrs of reduction in cigarette smoking by Dutch males.

    • © ERS Journals Ltd

    References

    1. ↵
      Hoogendoorn M, Rutten-van Molken MPMH, Hoogenveen RT, et al. A dynamic population model of disease progression in COPD. Eur Respir J 2005;26:223–233.
      OpenUrlAbstract/FREE Full Text
    2. ↵
      Forey B, Hamling J, Lee P, Wald N. International Smoking Statistics. A Collection of Historical Data from 30 Economically Developed Countries. 2nd Edn. Wolfson Institute of Preventive Medicine, London and Oxford, Oxford University Press, 2002
    3. ↵
      LoddenkemperRed. European Lung White Book. Huddersfield, European Respiratory Society, 2003
    4. ↵
      Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr. Mortality from Smoking in Developed Countries 1950–2000. 2nd Edn. Oxford, Oxford University Press, 2004
    5. ↵
      Mannino D. Chronic obstructive pulmonary disease in 2025: where are we headed?. Eur Respir J 2005;26:189
      OpenUrlFREE Full Text
    6. ↵
      Pride NB. Smoking cessation: effects on symptoms, spirometry and future trends in COPD. Thorax 2001;56: Suppl. 2 7–10.
      OpenUrl
    View Abstract
    PreviousNext
    Back to top
    View this article with LENS
    Vol 27 Issue 1 Table of Contents
    European Respiratory Journal: 27 (1)
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Projections of COPD in males in the Netherlands
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Print
    Citation Tools
    Projections of COPD in males in the Netherlands
    N. B. Pride
    European Respiratory Journal Jan 2006, 27 (1) 240-241; DOI: 10.1183/09031936.06.00107605

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Projections of COPD in males in the Netherlands
    N. B. Pride
    European Respiratory Journal Jan 2006, 27 (1) 240-241; DOI: 10.1183/09031936.06.00107605
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
      • References
    • Info & Metrics
    • PDF
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • Risk factors for disease progression in fibrotic hypersensitivity pneumonitis
    • Optimised surveillance of bronchial dysplasia in risky population
    • Reply: Risk factors for disease progression in fibrotic hypersensitivity pneumonitis
    Show more Correspondence

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About the ERJ

    • Journal information
    • Editorial board
    • Reviewers
    • Press
    • Permissions and reprints
    • Advertising

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Publication ethics and malpractice
    • Submit a manuscript

    For readers

    • Alerts
    • Subjects
    • Podcasts
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Print ISSN:  0903-1936
    Online ISSN: 1399-3003

    Copyright © 2023 by the European Respiratory Society